Nomori H, Yamazaki I, Shiraishi A, et al. - For treating T1N0M0 non-small cell lung cancer, researchers assessed the local control and complications with cryoablation using liquid nitrogen. Researchers performed a retrospective observational study including a total of 101 patients with T1N0M0 non-small cell lung cancer (NSCLC) who had undergone cryoablation between 2013 and 2019. According to the maximum tumor diameter, individuals were classified into four groups as follows: ≤0.9 cm (n = 21), 1.0–1.2 (n = 29), 1.3–1.7 (n = 24), and ≥1.8 (n = 27). For T1N0M0 NSCLC, the local control and recurrence-free survival of cryoablation was satisfactory for tumors < 1.8 cm. It was reported that the decrease in pulmonary function was just 3%, while the main complication was pneumothorax.  No treatment-related mortality was reported.